Summary
Stock: Krka, d. d. (WSE: KRK) common equity
Market cap: β¬2.80bn
Rating: Buy
Price: β¬89.80
Target: β¬126.59
β’β’β’
Setting the stage
Krka, d. d., founded in 1954, isΒ a Slovenian generic pharmaceutical manufacturer. The company makes money by developing, producing, marketing, and selling prescription and non-prescription generic drugs inβ¦
Keep reading with a 7-day free trial
Subscribe to ππππ’πππ to keep reading this post and get 7 days of free access to the full post archives.